Pediatric ID News

Parental concern about the safety of childhood vaccines increased significantly during the first 2 years of the COVID-19 pandemic, although confidence in vaccines remained high, according to research published in Pediatrics.

As of Aug. 5, approximately half of all eligible Americans aged 5 years or older had received their first COVID-19 booster vaccine, according to data published Thursday in MMWR.

Most patients when filling an antibiotic prescription are counseled to “take all of the antibiotic to complete the course, even if you feel better.”

I first became interested in the medical field while dissecting a frog in my junior high biology class.

After requesting emergency use authorization for their omicron-adapted COVID-19 vaccine in people aged 12 years and older, Pfizer and BioNTech said Tuesday they are also working with the FDA on bringing a booster to younger children.

The CDC on Monday recommended Novavax’s COVID-19 vaccine for use in adolescents aged 12 to 17 years.

Anthony S. Fauci, MD, announced Monday that he will step down as director of the National Institute of Allergy and Infectious Diseases in December after 38 years in the position.

About 7% of children hospitalized with COVID-19 at major pediatric hospitals in the United States experienced a neurologic complication of some kind, even if they were otherwise healthy, a study in Pediatrics reported.

Healio spoke with Sonja C. O’Leary, MD, medical director of school-based health centers at Denver Health and chair of the AAP’s Council on School Health, about updated CDC guidance and other challenges facing K-12 systems this year.

The FDA has approved the oral influenza medication Xofluza for children aged 5 to 11 years who have been symptomatic for no more than 48 hours, Genentech announced.